logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

Alphabet vs. Meta: Which Digital Ad Titan Is the Smarter Buy Right Now?

Why Novartis Outshines Amarin as a Safe Bet in a Volatile Market

Mar 3, 2026

Life Science

Flu Season Fades, Abbott Stumbles: Is the 54-Year Dividend King Still Worth the Crown?

Teva’s Earnings Beat, Stock Doubles: Buy, Sell, or Hold?

Mar 2, 2026

Life Science

医疗保健精选——XBiotech完成向强生出售bermekimab,Acceleron Pharma与Fulcrum Therapeutics合作

Temptation of $150 Billion Weight Loss Drug Market Irresistible, Novo Nordisk Expands Production Against the Trend

Mar 2, 2026

Life Science

到2030年,这些股票可能是表现最佳的生物科技股

Structure Therapeutics Surges 214% in One Year, Faces Institutional Reduction Cashing Out USD 15.52 Million

Feb 27, 2026

Life Science

到2030年,这些股票可能是表现最佳的生物科技股

Analysts See 3x Upside Potential, Overlooked Cancer Diagnostics Company Telix Could Be an Investment Dark Horse

Feb 26, 2026

Life Science

百时美施贵宝押注未来,哪些管线将成为新增长支柱?

Following Billionaire Laffont? Analyzing the Investment Thesis for Moderna

Feb 25, 2026

Life Science

Hedge Fund BVF Makes Massive Bet on Structure Therapeutics as Stock Skyrockets 214%

Hedge Fund BVF Makes Massive Bet on Structure Therapeutics as Stock Skyrockets 214%

Feb 25, 2026

Life Science

Parabilis Shatters Biotech IPO Record, Stock Surges 58% in Nasdaq Debut

What Will Drive Regeneron Pharmaceuticals in the Next Decade?

Feb 24, 2026

Life Science

Double Victory for Eli Lilly: Superior Weight-Loss Data & Bold Vaccine Expansion

Gilead to Acquire Arcellx for Up to $7.8 Billion, Doubling Down on Next-Generation CAR-T Therapy

Feb 24, 2026

Life Science

如何规划五万美元投资?三大科技领军企业的长期价值分析

Aiming at a Billion-Dollar Market, Pfizer Doubles Down on Obesity Therapies in China

Feb 24, 2026

Life Science

重金布局能源,谷歌47.5亿美元收购Intersect

This Weight-Loss Drug ‘Dark Horse’ Could Take You for a Ride

Feb 23, 2026

Life Science

Goeasy Shares Crater 57% After Suspending Dividend, Flagging Bad Loan Charges

Novo Nordisk Shares Plunge 16% as CagriSema Lags Behind Lilly’s Drug in Key Trial

Feb 23, 2026

Life Science

Forget AI and Weight-Loss Drugs: Why Vertex Pharmaceuticals Is the Silent Compounder You Need

Forget AI and Weight-Loss Drugs: Why Vertex Pharmaceuticals Is the Silent Compounder You Need

Feb 22, 2026

Life Science

英特尔押注AI未来,传计划收购SambaNova

Will One Comment from Eli Lilly Turn Around Novo Nordisk’s Stock?

Feb 20, 2026

Life Science

富国银行:从英伟达震荡看AI投资新走向

Is the Current US Stock Market Lacking Bargains? These Two High-Yield Dividend Stocks Are Worth Watching

Feb 19, 2026

Energy, Life Science

硅谷权力更迭,Alphabet凭AI强势回归

Searching for the Next ‘Star Stock’? Wall Street Recommends These Two Biotech Stocks

Feb 19, 2026

Life Science

Can Viking Therapeutics Really Soar 300%? Why Wall Street Is Betting Big on This Biotech Stock

Can Viking Therapeutics Really Soar 300%? Why Wall Street Is Betting Big on This Biotech Stock

Feb 19, 2026

Life Science

ImmunityBio Soars Over 40% as European Commission Approves Bladder Cancer Drug Anktiva

ImmunityBio Soars Over 40% as European Commission Approves Bladder Cancer Drug Anktiva

Feb 18, 2026

Life Science

  • ‹‹ Previous
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada